Unpleasant People May Be More Prone to Stroke: People with antagonistic or disagreeable personalities have vascular abnormalities that may make them more prone to strokes and perhaps other cardiovascular events, researchers said. Carotid artery intima-media thickness, which is linked to stroke risk, was significantly greater in individuals who rated low …
Read More »Newsflash: Lilly Insulin Pens Being Discontinued
Lilly Insulin Pens Being Discontinued Lilly will no longer be manufacturing the original Prefilled Pen that contains Humalog®, Humalog® Mix75/25™, and Humalog® Mix50/50™ as of January 1, 2011. In addition, there is currently a limited supply of the original Prefilled Pen devices containing the Humalog brand of insulin. The limited …
Read More »Roche Diabetes Care Highlights Infusion-site Management with Awareness Week
Roche Diabetes Care Highlights Infusion-site Management with Awareness Week: One of the many challenges for people with Type 1 diabetes is management of the infusion site, the place where a needle or plastic tube is inserted under the skin for administering insulin. Management of the infusion site involves choosing, cleaning …
Read More »What We Can Do to Combat Obesity
What We Can Do to Combat Obesity: This week, the Centers for Disease Control and Prevention reported that in 2009, no state had met a target of reducing obesity prevalence among adults to 15 percent. Dr. Teresa Quattrin from the CDC states that, “People are eating more, and eating less …
Read More »Lilly/Amylin amassing significant pre-launch stock of Bydureon, the once-a-week form of Byetta
Lilly/Amylin amassing significant pre-launch stock of Bydureon, the once-a-week form of Byetta. October 22nd, 2010 is the likely date Bydureon will be ready to launch. Byetta has only lost 7.7% market share to Victoza.
Read More »Once-monthly exenatide begins phase 1a clinical trials
Once-monthly exenatide begins phase 1a clinical trials: Versartis has announced the start of phase 1a clinical trials for VRS-859, its once-monthly exenatide. The drug, also called E-XTEN, is a fusion protein containing the GLP-1 analog exenatide and the hydrophilic peptide XTEN. Versartis has proposed that the 100 mg monthly dose …
Read More »Cashew Extract May Combat Diabetes
Cashew Extract May Combat Diabetes: New research reveals that an extract of cashew seeds may help fight diabetes. In a series of test-tube experiments, scientists found that cashew seed extract helped muscle cells to absorb blood sugar. According to the study’s authors, this finding suggests that cashew seed extract could …
Read More »Why Some Obese People Go On to Become Diabetic While Others Do Not
Why Some Obese People Go On to Become Diabetic While Others Do Not: It is common to find obese people (even morbidly obese people) who are healthier than their condition would normally allow. Working with subjects with a BMI of about 56, a team of researchers investigated the inflammatory and …
Read More »People with Diabetes Guaranteed Health Insurance
People with Diabetes Guaranteed Health Insurance: This rule comes under the new Patient Protection and Affordable Care Act. The rules will help simplify the denial process and create consistency in all 50 states. “In order to stay healthy, people with diabetes have to manage their disease with supplies like test …
Read More »Alcohol Consumption and Retinopathy
Alcohol Consumption and Retinopathy — Visual Acuity: The association between alcohol consumption and diabetic retinopathy and deterioration of visual acuity in individuals with Type 2 diabetes was studied. In a cohort analysis of 1,239 participants with Type 2 diabetes aged 55-81 years enrolled in the AdRem study, a sub-study of …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.